Henrik Calum Selected Research

Henrik Calum Research Topics

8	Wounds and Injuries (Trauma) 12/2023 - 03/2013
7	Infections 07/2022 - 09/2003
4	Inflammation (Inflammations) 11/2017 - 02/2009
1	Urinary Tract Infections (Urinary Tract Infection) 12/2023
1	Bacteriuria 12/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 07/2022
1	COVID-19 01/2021
1	Blister (Bulla) 11/2017
1	Pain (Aches) 11/2017
1	Spondylitis 04/2014
1	Burns 01/2014
1	Persistent Infection 02/2005

9	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 02/2005
4	Ciprofloxacin (Cipro)FDA LinkGeneric 12/2023 - 01/2020
4	AlginatesIBA 12/2023 - 09/2003
3	CytokinesIBA 01/2021 - 09/2003
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2009 - 02/2009
2	Tobramycin (Nebcin)FDA LinkGeneric 12/2009 - 12/2005
1	1,1'- (4,4,7,7- tetramethyl- 4,7- diazaundecamethylene)bis- 4- (3- methyl- 2,3- dihydro(benzo- 1,3- thiazole)- 2- methylidene)quinolinium (TOTO)IBA 12/2023
1	MacrolidesIBA 07/2022
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2021
1	IgYIBA 01/2021
1	FibrinIBA 04/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2017
1	CoagulaseIBA 11/2017
1	GelsIBA 11/2017
1	Zinc Sulfate FDA Link 11/2017
1	Itraconazole (Sporanox)FDA LinkGeneric 04/2014
1	Interleukin-1beta (Interleukin 1 beta)IBA 03/2013
1	DAPIIBA 03/2013
1	Chemokine CXCL2IBA 12/2009
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2003